PubMed

Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.

Al-Jamal RT, Eskelin S, Pyrhönen S, Kivelä T.

Acta Oncol. 2009;48(3):476-9. No abstract available. PMID: 19031163 [PubMed - indexed for MEDLINE]Related articles

Mortality after uveal and conjunctival melanoma: which tumour is more deadly?

Kujala E, Tuomaala S, Eskelin S, Kivelä T.

Acta Ophthalmol. 2009 Mar;87(2):149-53. Epub 2008 Oct 15.PMID: 18937804 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas.

Eskelin S, Tommila P, Palosaari T, Kivelä T.

Acta Ophthalmol. 2008 Nov;86(7):794-9. Epub 2008 Aug 27.PMID: 18759802 [PubMed - indexed for MEDLINE]Related articles

Transformation of nevus to melanoma.

Kivelä T, Eskelin S.

Ophthalmology. 2006 May;113(5):887-8.e1. No abstract available. PMID: 16650691 [PubMed - indexed for MEDLINE]Related articles

Metastatic uveal melanoma.

Kivelä T, Eskelin S, Kujala E.

Int Ophthalmol Clin. 2006 Winter;46(1):133-49. Review. No abstract available. PMID: 16365560 [PubMed - indexed for MEDLINE]Related articles

A prognostic model and staging for metastatic uveal melanoma.

Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S, Kivelä T.

Cancer. 2003 Jan 15;97(2):465-75.PMID: 12518371 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.

Pyrhönen S, Hahka-Kemppinen M, Muhonen T, Nikkanen V, Eskelin S, Summanen P, Tarkkanen A, Kivelä T.

Cancer. 2002 Dec 1;95(11):2366-72.PMID: 12436444 [PubMed - indexed for MEDLINE]Related articlesFree article

Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites.

Tuomaala S, Eskelin S, Tarkkanen A, Kivelä T.

Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3399-408.PMID: 12407149 [PubMed - indexed for MEDLINE]Related articlesFree article

Imaging to detect metastases from malignant uveal melanoma.

Eskelin S, Kivelä T.

Arch Ophthalmol. 2002 May;120(5):676. No abstract available. PMID: 12003636 [PubMed - indexed for MEDLINE]Related articles

Mode of presentation and time to treatment of uveal melanoma in Finland.

Eskelin S, Kivelä T.

Br J Ophthalmol. 2002 Mar;86(3):333-8.PMID: 11864894 [PubMed - indexed for MEDLINE]Related articlesFree article

Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance.

Kivelä T, Eskelin S, Mäkitie T, Summanen P.

Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2085-93.PMID: 11481276 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.

Eskelin S, Pyrhönen S, Summanen P, Hahka-Kemppinen M, Kivelä T.

Ophthalmology. 2000 Aug;107(8):1443-9.PMID: 10919885 [PubMed - indexed for MEDLINE]Related articles

Screening for metastatic malignant melanoma of the uvea revisited.

Eskelin S, Pyrhönen S, Summanen P, Prause JU, Kivelä T.

Cancer. 1999 Mar 1;85(5):1151-9.PMID: 10091801 [PubMed - indexed for MEDLINE]Related articlesFree article